| MeSH term | MeSH ID | Detail |
|---|---|---|
| Uremia | D014511 | 33 associated lipids |
| Kidney Failure, Chronic | D007676 | 51 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Neoplasms, Experimental | D009374 | 10 associated lipids |
| Hypercalcemia | D006934 | 13 associated lipids |
| Neovascularization, Pathologic | D009389 | 39 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Autoimmune Diseases | D001327 | 27 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Tian QX et al. | [Effects of calcitonin on osteoblast cell proliferation and OPG/RANKL expression: experiment with mouse osteoblasts]. | 2007 | Zhonghua Yi Xue Za Zhi | pmid:17785093 |
| Wang BL et al. | [Regulation of receptor activator of nuclear factor kappaB ligand and osteoprotegerin expression by prostaglandin E2 in osteoblastic-like cells]. | 2008 | Zhonghua Yi Xue Za Zhi | pmid:19062743 |
| Xiang GD et al. | [Changes in plasma concentrations of osteoprotegerin before and after levothyroxine replacement therapy in hypothyroid patients]. | 2007 | Zhonghua Yi Xue Za Zhi | pmid:17988532 |
| Zhang XM et al. | [Adiponectin regulates the expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand in human osteoblast]. | 2008 | Zhonghua Yi Xue Za Zhi | pmid:18956641 |
| Xiao XH et al. | [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro]. | 2004 | Zhonghua Yi Xue Za Zhi | pmid:15730627 |
| Zhong N et al. | [Relationship between polymorphism of parathyroid hormone and bone mineral density and relevant biochemical indicators in women]. | 2006 | Zhonghua Yi Xue Za Zhi | pmid:16677544 |
| Cheng Q et al. | [Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women]. | 2004 | Zhonghua Yi Xue Za Zhi | pmid:15059506 |
| Jia P et al. | [The effect of ferric ion on the differentiation of osteoclast and bone resorption]. | 2012 | Zhonghua Yi Xue Za Zhi | pmid:23158430 |
| Xiang GD et al. | [Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients]. | 2007 | Zhonghua Yi Xue Za Zhi | pmid:17686254 |
| Fang TY et al. | [Serum osteoprotegrin and serum bone gamma-carboxyglutamine acid-containing protein are correlated with bone mineral density in normal women]. | 2004 | Zhonghua Yi Xue Za Zhi | pmid:15569454 |
| Yano S et al. | Static and dynamic hypergravity responses of osteoblasts and osteoclasts in medaka scales. | 2013 | Zool. Sci. | pmid:23480382 |